|
If one is diagnosed with HIV, will need to get a
baseline assessment of his/her immune system; four weeks after starting
anti-HIV therapy and then every three to four months if you continue
therapy. The test used is the CD4 test which measures the number of CD4
cells (also known as T-helper cells) in the blood and assesses the
status of the immune system.
CD4 cells are a type of white blood cell that fight infection, and
they play an important role in our immune system. They help to identify,
attack, and destroy specific bacteria, fungi, and other germs that
affect the body. CD4 cells are made in the spleen, lymph nodes, and
thymus gland, and they circulate throughout the body in the bloodstream.
CD4 cells are a major target for the HIV virus, which binds to the
surface of CD4 cells, enters them, and either reproduces immediately,
killing them in the process, or remains in a resting state, reproducing
later. As the HIV virus gets into the cell and replicates, the number of
CD4 cells in the blood gradually declines. As HIV disease progresses,
the CD4 count will go down and as treatment reduces the progression, the
CD4 count will go back up.
This test measures
the number of CD4 cells (also known as T-helper cells) in your
blood and assesses the status of your immune system. CD4 cells are a
type of white blood cell that fight infection, and they play an
important role in your immune system. They help to identify, attack, and
destroy specific bacteria, fungi, and other germs that affect the body.
The
CD4 count points indicates the immune system strength is, how far HIV
disease has advanced (the stage of the disease), and helps predict the
risk of complications and debilitating infections. The CD4 count is most
useful when it is compared with the count obtained from an earlier test.
The CD4 count is used in combination with the viral load test, which
measures the level of HIV in the blood, to determine the staging and
outlook of the disease.
The CD4 count is also used to identify possible health problems for
which you may be at risk and to determine which medications might be
helpful
A CD4 count and a
viral load test are ordered when a person is first diagnosed with
HIV as part of a baseline measurement. Both tests should be repeated
about two to eight weeks after starting or changing anti-HIV therapy. If
treatment is maintained, a CD4 count should be performed every three to
six months thereafter.
Normal CD4 counts in adults range from 500 to 1,500 cells per cubic
millimeter of blood.
In general, the CD4 count goes down as HIV disease progresses. Any
single CD4 count value may differ from the last one even though your
health status has not changed. You should not place too much importance
on any one result. What is more important than any single value is the
pattern of CD4 counts over time.
If your CD4 count declines over several months, your doctor may
recommend beginning or changing anti-HIV treatment and/or starting
preventive treatment for opportunistic infections like Pneumocystis
carinii pneumonia (PCP). Your CD4 count should increase or stabilize in
response to effective combination anti-HIV therapy.
According to public health guidelines, preventive therapy should be
started when an HIV-positive person who has no symptoms registers a CD4
count under 200. Some physicians will opt to consider treatment earlier,
at 350. The Centers for Disease Control and Prevention considers
HIV-infected persons who have CD4 counts below 200 to have AIDS,
regardless of whether they are sick or well.
Because reference
values are dependent on many factors, including patient age, gender,
sample population, and test method, numeric test results have different
meanings in different labs. It Is therefore important to use the same
laboratory for serial monitoring of the CD4 count.
The CD4 count tends
to be lower in the morning and higher in the evening. Acute illnesses,
such as pneumonia, influenza, or herpes simplex virus infection, can
cause the CD4 count to decline temporarily. Cancer chemotherapy can
dramatically lower the CD4 count. Regardless, it can be used as an
effective monitoring tool if the more sensitive HIV viral load test is
not available.
The CD4 count does not always reflect how someone with HIV disease feels
and functions. For example, some people with higher counts are ill and
have frequent complications, and some people with lower CD4 counts have
few medical complications and function well.
When AIDS is present and a CD4 count is lower than 200 there is a risk
for what are called opportunistic infections due to decreased immune
system difenses.
Opportunistic Infections Included in the CDC's Definition of AIDS
| |
-
Pneumocystis Carinii Pneumonia (PCP)
-
Kaposi's Sarcoma (KS)
- HIV
wasting syndrome
-
Non-Hodgkin's lymphoma
-
Cryptococcosis, extrapulmonary
- HIV
encephalopathy (AIDS Dementia)
-
Mycobacterium Avium Intracellulare (MAC or MAI)
-
Candidiasis of the esophagus, trachea, bronchi, or lungs
-
Cryptosporidiosis, chronic intestinal
-
Cytomegalovirus disease (CMV)
-
Tuberculosis (outside of the lungs)
-
Herpes simplex virus infection
-
Progressive Multifocal Leukoencephalopathy (PML)
-
Primary lymphoma of the brain
-
Toxoplasmosis of the brain
-
Histoplasmosis
-
Isoporiasis, chronic intestinal
-
Coccidioidomycosis
-
Salmonella septicemia
-
Bacterial infections, recurrent, <13 years
-
Lymphoid interstitial pneumonia/pulmonary lymphoid
hyperplasia, <13 years.
- Pulmonary
tuberculosis
-
Recurrent bacterial pneumonia (two or more episodes in one
year)
Invasive cervical cancer
|
|
Note that more recent definitions finally include
illnesses specific to women with HIV. Although this list has been
revised several times since it was first developed, it does not include
all of the illnesses experienced by people with HIV-related immune
suppression
|